XML 20 R33.htm IDEA: XBRL DOCUMENT v2.4.1.9
Financial Instruments (Tables)
9 Months Ended
Mar. 31, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Available-for-sale Securities
The amortized cost and fair value of available-for-sale investments at March 31, 2015 are as follows:
 
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair
Value
Fixed income mutual funds
$
222,088

 
$
301

 
$

 
$
222,389

Government bonds
63,594

 
5

 
6

 
63,593

Corporate bonds
138,319

 

 
154

 
138,165

Asset-backed and mortgage-backed securities
10,753

 
2

 
17

 
10,738

Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value
 
 
 
 
 
 
 
 
 
 
 
 
Investments Classified by Contractual Maturity Date
The contractual maturities of available-for-sale investments at March 31, 2015 are as follows:
 
Amortized
Cost
 
Fair
Value
Less than one year
$
19,245

 
$
19,239

One to three years
179,575

 
179,434

Above three years
13,846

 
13,823

Schedule of Carrying Values and Estimated Fair Values of Debt Instruments
he carrying value of long-term debt (excluding capital leases) and estimated fair value of long-term debt (excluding capital leases) are as follows:
 
 
March 31,
2015
 
June 30,
2014
Carrying value of long-term debt (excluding capital leases)
 
$
2,939,620

 
$
1,508,420

Estimated fair value of long-term debt (excluding capital leases)
 
3,295,663

 
1,708,723

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The following summarizes the location and fair value of derivative financial instruments reported in the Consolidated Balance Sheet as of March 31, 2015 and June 30, 2014:

 
 
Balance Sheet Caption
 
March 31,
2015
 
June 30,
2014
Net investment hedges
 
 
 
 
 
 
Cross-currency swap contracts
 
Other assets
 
$
26,747

 
$

Cross-currency swap contracts
 
Other liabilities
 

 
45,790

Cash flow hedges
 
 
 
 
 
 
Costless collar contracts
 
Non-trade and notes receivable
 
7,712

 
3,508

Forward exchange contracts
 
Non-trade and notes receivable
 
63

 
(41
)
Costless collar contracts
 
Other accrued liabilities
 
6,651

 
378

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance
Gains (losses) on derivative financial instruments that were recorded in the Consolidated Statement of Income are as follows:
 
 
Three Months Ended
 
Nine Months Ended
 
March 31,
 
March 31,
 
2015
 
2014
 
2015
 
2014
Forward exchange contracts
$
(331
)
 
$
442

 
$
148

 
$
(182
)
Costless collar contracts
(424
)
 
766

 
(1,788
)
 
7,486

Gains (losses) on derivative and non-derivative financial instruments that were recorded in accumulated other comprehensive (loss) in the Consolidated Balance Sheet are as follows:
 
 
Three Months Ended
 
Nine Months Ended
 
March 31,
 
March 31,
 
2015
 
2014
 
2015
 
2014
Cross-currency swap contracts
$
22,684

 
$
(2,393
)
 
$
44,813

 
$
(13,881
)
Foreign denominated debt
17,151

 
(1,013
)
 
42,296

 
(7,895
)
Schedule of Financial Assets & Liabilities Measured at Fair Value
A summary of financial assets and liabilities that were measured at fair value on a recurring basis at March 31, 2015 and June 30, 2014 are as follows:
 
 
 
 
Quoted Prices

 
Significant Other

 
Significant

 
 
Total

 
In Active

 
Observable

 
Unobservable

 
 
Value at

 
Markets

 
Inputs

 
Inputs

 
 
March 31, 2015

 
(Level 1)

 
(Level 2)

 
(Level 3)

Assets:
 
 
 
 
 
 
 
 
Fixed income mutual funds
 
$
222,389

 
$
59,450

 
$
162,939

 
$

Government bonds
 
63,593

 
63,593

 

 

Corporate bonds
 
138,165

 
138,165

 

 

Asset-backed and mortgage-backed securities
 
10,738

 

 
10,738

 

Derivatives
 
34,522

 

 
34,522

 

Liabilities:
 
 
 
 
 
 
 
 
Derivatives
 
6,651

 

 
6,651

 

 
 
 
 
Quoted Prices

 
Significant Other

 
Significant

 
 
Total

 
In Active

 
Observable

 
Unobservable

 
 
Value at

 
Markets

 
Inputs

 
Inputs

 
 
June 30, 2014

 
(Level 1)

 
(Level 2)

 
(Level 3)

Assets:
 
 
 
 
 
 
 
 
Derivatives
 
$
3,508

 
$

 
$
3,508

 
$

Liabilities:
 
 
 
 
 
 
 
 
Derivatives
 
46,209

 

 
46,209